Unbalanced Placental Expression of Imprinted Genes in Human Intrauterine Growth Restriction

Placenta

Volumn 27, Issue 6-7, 2006, Pages 540-549

  McMinn, J ^a   Wei, M ^a   Schupf, N ^a   Cusmai, J ^a   Johnson, E B ^a   Smith, A C ^b   Weksberg, R ^b,c   Thaker, H M ^a   Tycko, B ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Imprinting; Intrauterine growth restriction; IUGR; MEG3; MEST; PHLDA2; Placenta

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANGIOTENSIN 1 RECEPTOR; CARRIER PROTEIN; CORTICOTROPIN RELEASING FACTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; DOWN SYNDROME CRITICAL REGION PROTEIN 1; GLUTAREDOXIN; INDOLEAMINE 2,3 DIOXYGENASE; LEPTIN; MESSENGER RNA; PROTEIN; PROTEIN GATM; PROTEIN GNAS; PROTEIN MEG3; PROTEIN MEST; PROTEIN PHLDA2; PROTEIN PLAGL1; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; DNA METHYLATION; DNA MICROARRAY; GENE EXPRESSION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INTRAUTERINE GROWTH RETARDATION; NORTHERN BLOTTING; PATHOGENESIS; PLACENTA; PLACENTA VILLUS; PRIORITY JOURNAL; RNA TRANSLATION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TISSUE GROWTH;

ADULT; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMIC IMPRINTING; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY; PROTEINS; RNA, MESSENGER;

EID: 33645902182     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.07.004     Document Type: Article

References (52)

1. Wilkins-Haug L., Roberts D.J., and Morton C.C. Confined placental mosaicism and intrauterine growth retardation: a case-control analysis of placentas at delivery. Am J Obstet Gynecol 172 (1995) 44-50
2. Robinson W.P., Barrett I.J., Bernard L., Telenius A., Bernasconi F., Wilson R.D., et al. Meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast, and increased risk of fetal intrauterine growth restriction. Am J Hum Genet 60 (1997) 917-927
3. Kalousek D.K. Current topic: confined placental mosaicism and intrauterine fetal development. Placenta 15 (1994) 219-230
4. Bianci D.W., Cromblehome T.M., and D'Alton M.E. Fetology: diagnosis & management of the fetal patient (2000), McGraw-Hill
5. Tycko B., and Morison I.M. Physiological functions of imprinted genes. J Cell Physiol 192 (2002) 245-258
6. Caspary T., Cleary M.A., Perlman E.J., Zhang P., Elledge S.J., and Tilghman S.M. Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev 13 (1999) 3115-3124
7. Takahashi K., Kobayashi T., and Kanayama N. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 6 (2000) 1019-1025
8. Kanayama N., Takahashi K., Matsuura T., Sugimura M., Kobayashi T., Moniwa N., et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 8 (2002) 1129-1135
9. Eggenschwiler J., Ludwig T., Fisher P., Leighton P.A., Tilghman S.M., and Efstratiadis A. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev 11 (1997) 3128-3142
10. Constancia M., Hemberger M., Hughes J., Dean W., Ferguson-Smith A., Fundele R., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417 (2002) 945-948
11. Frank D., Fortino W., Clark L., Musalo R., Wang W., Saxena A., et al. Placental overgrowth in mice lacking the imprinted gene Ipl. Proc Natl Acad Sci U S A 99 (2002) 7490-7495
12. Salas M., John R., Saxena A., Barton S., Frank D., Fitzpatrick G., et al. Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev 121 (2004) 1199-1210
13. Monk D., Bentley L., Hitchins M., Myler R.A., Clayton-Smith J., Ismail S., et al. Chromosome 7p disruptions in Silver Russell syndrome: delineating an imprinted candidate gene region. Hum Genet 111 (2002) 376-387
14. Holmes R., Montemagno R., Jones J., Preece M., Rodeck C., and Soothill P. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum Dev 49 (1997) 7-17
15. Li C.M., Guo M., Borczuk A., Powell C.A., Wei M., Thaker H.M., et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160 (2002) 2181-2190
16. Li C.M., Kim C.E., Margolin A.A., Guo M., Zhu J., Mason J.M., et al. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am J Pathol 165 (2004) 1943-1953
17. Saxena A., Frank D., Panichkul P., Van den Veyver I.B., Tycko B., and Thaker H. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole. Placenta 24 (2003) 835-842
18. Lefebvre L., Viville S., Barton S.C., Ishino F., Keverne E.B., and Surani M.A. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat Genet 20 (1998) 163-169
19. Mayer W., Hemberger M., Frank H.G., Grummer R., Winterhager E., Kaufmann P., et al. Expression of the imprinted genes MEST/Mest in human and murine placenta suggests a role in angiogenesis. Dev Dyn 217 (2000) 1-10
20. Oken E., Kleinman K.P., Rich-Edwards J., and Gillman M.W. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 3 (2003) 6
21. McMinn J., Wei M., Sadovsky Y., Thaker H., and Tycko B. Imprinting of PEG1/MEST isoform 2 in human placenta. Placenta (2005)
22. Thaker H.M., Berlin A., Tycko B., Goldstein D.P., Berkowitz R.S., Castrillon D.H., et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med 49 (2004) 630-636
23. Redline R.W., Boyd T., Campbell V., Hyde S., Kaplan C., Khong T.Y., et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 7 (2004) 237-249
24. Baker J., Liu J.P., Robertson E.J., and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 (1993) 73-82
25. Lage J.M. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content, and fetal omphaloceles: possible association with Beckwith-Wiedemann syndrome. Hum Pathol 22 (1991) 591-597
26. Drut R.M., and Drut R. Nonimmune fetal hydrops and placentomegaly: diagnosis of familial Wiedemann-Beckwith syndrome with trisomy 11p15 using FISH. Am J Med Genet 62 (1996) 145-149
27. McCowan L.M., and Becroft D.M. Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol 83 (1994) 813-817
28. Reish O., Lerer I., Amiel A., Heyman E., Herman A., Dolfin T., et al. Wiedemann-Beckwith syndrome: further prenatal characterization of the condition. Am J Med Genet 107 (2002) 209-213
29. Wadhwa P.D., Garite T.J., Porto M., Glynn L., Chicz-DeMet A., Dunkel-Schetter C., et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 191 (2004) 1063-1069
30. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
31. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2 (2001) 64-68
32. Reik W., Constancia M., Fowden A., Anderson N., Dean W., Ferguson-Smith A., et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol 547 (2003) 35-44
33. Weksberg R., Smith A.C., Squire J., and Sadowski P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12 Spec No 1 (2003) R61-R68
34. Haig D. Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol 35 (1996) 226-232
35. Roh C.R., Budhraja V., Kim H.S., Nelson D.M., and Sadovsky Y. Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta 26 (2005) 319-328
36. Robinson W.P., and Langlois S. Phenotype of maternal UPD(14). Am J Med Genet 66 (1996) 89
37. Georgiades P., Watkins M., Surani M.A., and Ferguson-Smith A.C. Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development 127 (2000) 4719-4728
38. Kotzot D. Maternal uniparental disomy 14 dissection of the phenotype with respect to rare autosomal recessively inherited traits, trisomy mosaicism, and genomic imprinting. Ann Genet 47 (2004) 251-260
39. Sandell L.L., Guan X.J., Ingram R., and Tilghman S.M. Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. Proc Natl Acad Sci U S A 100 (2003) 4622-4627
40. Cattanach B.M., Beechey C.V., and Peters J. Interactions between imprinting effects in the mouse. Genetics 168 (2004) 397-413
41. Fitzpatrick G.V., Soloway P.D., and Higgins M.J. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat Genet 32 (2002) 426-431
42. Poston L. Leptin and preeclampsia. Semin Reprod Med 20 (2002) 131-138
43. Jauniaux E., and Burton G.J. Pathophysiology of histological changes in early pregnancy loss. Placenta 26 (2005) 114-123
44. Shibata E., Ejima K., Nanri H., Toki N., Koyama C., Ikeda M., et al. Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 22 (2001) 566-572
45. Sahlin L., Ostlund E., Wang H., Holmgren A., and Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction. Placenta 21 (2000) 603-609
46. Takagi Y., Nikaido T., Toki T., Kita N., Kanai M., Ashida T., et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 444 (2004) 49-55
47. Benetos A., Gautier S., Ricard S., Topouchian J., Asmar R., Poirier O., et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 94 (1996) 698-703
48. Nalogowska-Glosnicka K., Lacka B.I., Zychma M.J., Grzeszczak W., Zukowska-Szczechowska E., Poreba R., et al. Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 6 (2000) 523-529
49. Takahashi N., Murakami H., Kodama K., Kasagi F., Yamada M., Nishishita T., et al. Association of a polymorphism at the 5′-region of the angiotensin II type 1 receptor with hypertension. Ann Hum Genet 64 (2000) 197-205
50. Hesser B.A., Liang X.H., Camenisch G., Yang S., Lewin D.A., Scheller R., et al. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104 (2004) 149-158
51. Yao Y.G., and Duh E.J. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?. Biochem Biophys Res Commun 321 (2004) 648-656
52. Dao D., Walsh C.P., Yuan L., Gorelov D., Feng L., Hensle T., et al. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting. Hum Mol Genet 8 (1999) 1337-1352